Clinical Trials Directory

Trials / Completed

CompletedNCT04402281

Use of suPAR Algorithm for the ED Decision Making

Use of Algorithm for Safer and More Efficient Decision Making in the ED

Status
Completed
Phase
Study type
Observational
Enrollment
1,800 (actual)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
All
Age
18 Years – 104 Years
Healthy volunteers
Accepted

Summary

Will the use of a clinical decision algorithm in the ED improve discharge or admission decisions.

Detailed description

Background Crowding and readmissions are common challenges in Emergency departments across Europe. The decision whether to admit or discharge the patient is challenging and is often based on clinical signs and symptoms e.g. blood pressure, pulse, respiratory rate, oxygen saturation and temperature. But some patients are unnecessarily admitted and may have been better off if sent home. Other patients may be discharged without - and one out of five patients are readmitted within a month raising the question whether the patient should have been admitted at first presentation in the ED. suPAR is a strong prognostic biomarker measured routinely in acute medical patients in some emergency department (ED) settings.suPAR is a broadly applicable biomarker of risk, and it has been developed an algorithm for simple interpretation of suPAR in clinical decisions for the study. Objective To evaluate the use of a clinical decision algorithm in the ED with the aim of improving discharge or admission decisions.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTsuPAR algoritmAll medical patients attending to the ED and who will have blood drawn for routine examination will be part of the study. In patients with low suPAR (green group, suPAR below 3 ng/ml) and in patients with high suPAR (red group, suPAR \> 6 ng/mL) the Intervention will be carried out

Timeline

Start date
2020-05-11
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2020-05-26
Last updated
2022-02-11

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT04402281. Inclusion in this directory is not an endorsement.